TGFB1 and cancer: Additionally, we observed a significant connection between EIF4A3 expression and the six immune subtypes (C1-wound healing, C2-IFN-gamma dominant, C3-inflammatory, C4-lymphocyte depleted, C5-immunologically quiet and C6-TGF-b dominant) in 17 types of cancer including ACC, BLCA, BRCA, COAD, HNSC, KICH, KIRC, KIRP, LIHC, LUAD, LUSC, MESO, OV, PRAD, SARC, STAD and UCEC (Fig. 7).